1	All subjects must sign an informed consent indicating that they are aware of the investigational nature of this study prior to any study-related procedures Patients must be registered with in the Dana Farber Cancer Institute 's Quality Assurance Office for Clinical Trials prior to treatment with ZD6474|ZD6474[297,303]||||||||||||
2	Vandetanib Patients must sign an authorization for the release of their protected health information|Vandetanib[304,314]|||||||||C1701110|1098413|1098413|vandetanib
